Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-06T06:25:46.420Z Has data issue: false hasContentIssue false

Bismuth iodoform paraffin paste: a review

Published online by Cambridge University Press:  12 July 2011

G J Crossland*
Affiliation:
Department of Otolaryngology, Addenbrooke's Hospital, Cambridge, UK
A P Bath
Affiliation:
Department of Otolaryngology, Norfolk and Norwich University Hospital, UK
*
Address for correspondence: Mr G J Crossland, Otology Fellow, Box 48, Clinic 10, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK Fax: +44 (0)1223 217559 E-mail: gcrossland@doctors.org.uk
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

This article reviews the literature pertaining to bismuth iodoform paraffin paste.

Overview:

Bismuth iodoform paraffin paste is used in most otolaryngology departments on a daily basis. Questions about its properties are common in postgraduate otolaryngology examinations. This article reviews bismuth iodoform paraffin paste's current and historical usage, constituents, properties, side effects, and radiographic properties, and its alternatives in otological and rhinological practice.

Type
Review Articles
Copyright
Copyright © JLO (1984) Limited 2011

Introduction

Bismuth iodoform paraffin paste (BIPP) is used in many otolaryngology departments on a daily basis. A literature search using the PubMed database identified no general review article on BIPP.1

This paper offers a review of the history, properties and side effects of BIPP. Alternatives to its usage in clinical practice are also suggested.

History

Bismuth iodoform paraffin paste was invented by James Rutherford Morrison, Professor of Surgery at the University of Durham. It was used widely in the First World War to dress soldiers’ suppurating battlefield wounds.Reference Morison2 Wounds were thoroughly debrided, any foreign material was removed, and they were then smeared with BIPP. This was left in situ for days or weeks, without disturbance. Prior to this, wounds were regularly inspected and redressed after the application of various ‘antiseptic’ solutions. The perceived improved antiseptic effect of the BIPP regime may have been due in part to the reduced opportunities for wound colonisation by pathogenic bacteria.Reference Fleming3

Some British army surgeons deviated from Rutherford Morrison's initial regime. They applied large amounts of BIPP to wounds, rather than a smear. Cases of both bismuth and iodoform toxicity followed, with some fatalities.Reference Gurd and McKim4, Reference Garrett Anderson and Chambers5

In smaller quantities, BIPP had relatively few adverse effects. It thus remained in use by otolaryngologists and maxillofacial and neurosurgical practitioners. Otolaryngologists began to find it particularly useful to aid healing and resolution of sepsis after mastoid surgery.Reference Tilley6

Constituents, properties and side effects

Bismuth iodoform paraffin paste gauze is sterile ribbon gauze impregnated with a paste consisting of one part bismuth subnitrate, two parts iodoform and one part sterilised liquid paraffin by weight.

Bismuth subnitrate

Bismuth compounds have been used to treat a variety of ailments for hundreds of years. They have been used topically as astringents and antiseptics, orally to treat gastrointestinal complaints, and parenterally to treat syphilis.Reference Kampmeier7 Bismuth subnitrate is included in BIPP for its astringent properties. It is soluble in weak acid but highly insoluble in water and alcohol. It may contribute to the antiseptic properties of BIPP by releasing dilute nitric acid on hydrolysis.Reference Chambers and Goldsmith8

Bismuth toxicity

Bismuth and its compounds are less toxic than antimony and polonium (its metalloid periodic table neighbours), and other heavy metals such as lead. Bismuth has a half-life for whole-body retention of 5 days, but it can remain in the kidney for years.Reference Nordberg9

Neurotoxicity due to the absorption of bismuth from BIPP is rare, but may be fatal if it is not recognised. Bismuth is thought to interfere with oxidative metabolism in the brain by binding the thiol groups of essential enzymes and by reducing cerebral blood flow.Reference Wilson10 Symptoms of toxicity include headache, nausea and stomatitis. Blue-black deposits in the gingiva may be seen, the so-called ‘bismuth line’.Reference Robinson11

In the 1970s, there was an outbreak of bismuth poisoning in France which affected hundreds of people. Bismuth was used widely at the time to treat a variety of gastro-intestinal complaints. The outbreak was postulated to be due to an increase in the prevalence of an otherwise benign group of gastro-intestinal microbes that promoted the methylation of bismuth, producing a more easily absorbed form.Reference Le Quesne12

Toxic blood levels of bismuth have been reported after nasal packing with BIPP-impregnated gauze for epistaxis.Reference Youngman and Harris13 Bismuth is absorbed through mucous membranes, but is absorbed more readily by physically injured tissues. This is worth bearing in mind if a patient has required repeated nasal packs for epistaxis, and thus has potentially traumatised nasal mucosa.

Bismuth subnitrate can also cause nitrite poisoning. This is indicated by vasomotor paralysis, tachycardia and asphyxia due to the formation of methaemoglobin.Reference Bunn and Forget14 Bismuth subnitrate is reduced to nitrite by resident bacteria in the bowel. Absorption of the nitrite causes the iron in haem to exist in the ferric (Fe3+) rather than ferrous (Fe2+) state, producing methaemoglobin, which cannot carry oxygen. Pulse oximetry in this situation may be misleading, showing an erroneous 85 per cent saturation reading.Reference Barker, Tremper and Hyatt15

Fatalities have occurred due to nitrite poisoning after the use of preparations containing bismuth subnitrate to treat diarrhoea.Reference Marcus and Joffe16 A 60 cm length of BIPP gauze, generally sufficient for an average nasal pack, contains approximately 5.6 g of bismuth subnitrate. Although some of the paste will undoubtedly be ingested following nasal packing, this quantity is unlikely to cause nitrite poisoning. There is only one report in the literature of raised methaemoglobin levels after using BIPP packing for epistaxis, and this was following resection of a nasal angiofibroma.Reference Nigam, Ruddy and Robin17

Iodoform

Iodoform is the constituent that gives BIPP its distinctive colour and smell. It is virtually insoluble in water, slightly soluble in alcohol, and freely soluble in chloroform and ether. Its chemical name is tri-iodomethane (CHI3).

Iodoform decomposes to liberate elemental iodine, which acts as an antiseptic. This process is hastened by high temperatures and by the presence of weak acid.

Early work speculated that nitric acid, liberated from bismuth subnitrate, potentiated the release of iodine from iodoform in BIPP, increasing its antiseptic efficacy.Reference Chambers and Goldsmith8

More recently, Nigam and Allwood found no appreciable iodine release in vitro on agar plates.Reference Nigam and Allwood18 However, iodine has been found in the urine of soldiers treated with larger amounts of BIPP, and O'Connor and colleagues’ case report, mentioned above, identified raised plasma iodine levels after BIPP use in a maxillectomy cavity.Reference Garrett Anderson and Chambers5, Reference O'Connor, Freeland, Heal and Rossouw19 These reports seem to offer quite compelling evidence that iodine is released in vivo.

In vitro studies provide poor evidence of an antimicrobial effect, as first noted by Fleming.Reference Fleming3 Nigam and Allwood identified slight inhibition of growth of Staphylococcus aureus exposed to BIPP paste.Reference Nigam and Allwood18Pseudomonas aeruginosa and Escherichia coli showed little or no inhibition of growth due to BIPP or its components. These authors speculated that, in a clinical context, the perceived antiseptic efficiency of BIPP may be due to the accompanying meticulous debridement of the wound.

Iodoform toxicity

Iodoform toxicity was relatively common when BIPP was applied to larger wounds.Reference Garrett Anderson and Chambers5 However, it has also been reported in modern practice. O'Connor et al. reported a case of severe iodoform toxicity in a patient receiving BIPP gauze packing following total maxillectomy.Reference O'Connor, Freeland, Heal and Rossouw19 The presence of a raised plasma iodine concentration was confirmed by spectrophotometry. The packing was removed, and the patient made a full recovery. These authors concluded that BIPP should be used with caution when packing cavities as large as those resulting from maxillectomy.

Bismuth iodoform paraffin paste allergy

If BIPP gauze is used to pack the ear canal after otological surgery, there is a well documented risk of atopic reaction. Two retrospective series have found an overall risk of BIPP allergy of 0.4 and 6 per cent, variously.Reference Farrell20, Reference Lim, Hughes and Oates21

A prospective patch testing study suggested that the true incidence of BIPP allergy is 12 per cent with previous exposure and 1 per cent without. The component part found to be responsible was iodoform, not iodine. Patch testing of patients previously exposed to BIPP was recommended, prior to any further surgery. Testing of patients not previously exposed to BIPP was not recommended, as the incidence of allergy was low and there was a risk of sensitisation.Reference Bennett, Bartle and Yung22

When the allergic reaction to BIPP has settled, there may be longer term consequences, such as increased risk of residual perforation after myringoplasty.Reference Lim, Hughes and Oates21

There is one reported case of delayed post-operative facial nerve palsy in association with BIPP allergy.Reference Jones23 This was thought to be a consequence of local inflammation. Bismuth iodoform paraffin paste is not known to be neurotoxic. Application of BIPP directly to the saphenous nerve of rats was not shown to affect nerve function. This study used Whitehead's varnish and Surgicel® (Ethicon, Somerville, New Jersey, USA) (oxidised regenerated cellulose) as comparators; these agents did cause reversible impairment of nerve function.Reference Loescher and Robinson24

Bismuth iodoform paraffin paste aspiration

Aspiration of BIPP has been reported. The patient made a good clinical recovery, and repeated chest X-rays showed relatively brisk dispersion of the paste.Reference Imison25

Alternatives to bismuth iodoform paraffin paste

In otological practice

In meatoplasty, alternative suturing techniques have been described that do not require BIPP packing to hold the meatal skin in position, with good long term outcomes.Reference Flook, Elloy and Johnston26

Xeroform® (Covidien, Mansfield, Massachusetts, USA) is petrolatum gauze with 3 per cent bismuth tribromophenate. It has been used as an iodide-free alternative to BIPP. However, there is a higher incidence of infective complications if it is not used in combination with ciprofloxacin and metronidazole antibiotic prophylaxis.Reference Chevretton, McRae and Booth27

In rhinological practice

Alternatives to BIPP for anterior nasal packing are now widely available.

Merocel® packs (Medtronic Xomed, Jacksonville, Florida, USA) are one example. They consist of compressed polyvinyl alcohol foam polymer sponges that expand on hydration.

Rapid Rhino® packs (Applied Therapeutics, Tampa, Florida, USA) consist of carboxymethylcellulose, a hydrocolloid material, wrapped around an inflatable polyvinyl chloride balloon. Both types of pack are easy to insert, and allow efficient nasal packing by non-specialist staff.

Two studies have compared anterior nasal packing with BIPP gauze and Merocel® packs. They found little difference in efficacy, although the sample sizes were small.Reference Corbridge, Djazaeri, Hellier and Hadley28, Reference Saab and Randall29

The level of discomfort on removal varies between different types of nasal pack. Netcell 5000® packs (Network Medical Products, Ripon, UK) have a gel coating and cause less discomfort on removal than Rapid Rhino® packs.Reference McDonald, Slater, Powell, Khalil and Garth30 In turn, Rapid Rhino® packs cause less discomfort on removal than standard Merocel® packs.Reference Badran, Malik, Belloso and Timms31, Reference Moumoulidis, Draper, Patel, Jani and Price32

Routine packing may not be justified after nasal septal surgery, as the incidence of epistaxis may be as low as 3 per cent.Reference Bajaj, Kanatas, Carr, Sethi and Kelly33 If nasal packs are to be used, Rapid Rhino® packs have been found, in a small study, to be more easily removed than Merocel® packs, and to cause less reactionary bleeding.Reference Ozcan, Vayisoglu, Kilic and Gorur34

After larger intra- or paranasal resections, packing with gauze impregnated with Whitehead's varnish (iodoform 10 g, benzoin 10 g, storax 7.5 g and balsam of Tolu 5 g, mixed to 100 mls in ether) may be a safer alternative to BIPP packing, due to a lower risk of iodoform toxicity.Reference Lim, Lew-Gor, Sandhu, Howard and Lund35

Kaltostat® (ConvaTec, Skillman, New Jersey, USA) is a sodium and calcium alginate fibre dressing that has been used as an equally efficacious alternative to traditional gauze packing for epistaxis. It has been shown to cause less bleeding on removal after turbinate surgery than petroleum jelly trouser or gloved finger packs.Reference McGlashan, Walsh, Dauod, Vowles and Gleeson36

Soluble nasal packing materials have been used to treat epistaxis for over 30 years.Reference Kamer and Parkes37 An increasing variety of such products exist. The most effective is FloSeal® (Baxter, Deerfield, Illinois, USA). It consists of collagen-derived particles and topical bovine-derived thrombin. Unfortunately, when used after sinus surgery it may result in increased adhesion formation.Reference Chandra, Conley and Kern38 FloSeal® is used in some units to treat acute epistaxis, with better results than traditional packing.Reference Cote, Barber, Diamond and Wright39, Reference Mathiasen and Cruz40

NasoPore® (Stryker Canada, Hamilton, Ontario, Canada) is a biodegradable synthetic polyurethane foam that can be used after sinus surgery, with no increased risk of adhesion formation.Reference Cote and Wright41, Reference Shoman, Gheriani, Flamer and Javer42

Surgicel® biodegradable packing can be locally applied, under endoscopic guidance, to treat posterior epistaxis. In a small study of eight patients, in the first three months following treatment, bleeding re-occurred in one individual.Reference Bhatnagar and Berry43

Tips for more efficient packing with bismuth iodoform paraffin paste gauze

Nasal cavity

Traditionally, Tilley's nasal dressing forceps are used to insert a loop of BIPP gauze along the floor of the nose, with further layers added superiorly. After inserting a few loops, the internal nasal valve makes packing of the superior nasal cavity difficult. It has been suggested that the superior nasal cavity should be packed first, and the BIPP gauze compressed superiorly with the dorsum of the Tilley's forceps as packing proceeds. This may minimise the risk of damage to the cribriform plate and result in more effective packing, especially in bleeding originating from the ethmoidal artery.Reference Amen and Pace-Balzan44

Proficiency in nasal packing can be improved by practice on a mannequin, or by using a ‘closed fist’ model.Reference Pettineo, Vozenilek, Kharasch, Wang and Aitchison45Reference Skilbeck and Oakley47

External auditory canal

Post-operative packing of the ear canal with BIPP gauze may be aided by the adjunctive use of an intravenous cannula casing.Reference Bernstein and Aucott48 The casing is trimmed by 5 mm at its distal end, and lubricated with Betadine® (Purdue Pharma, Stamford, Connecticut, USA) or water. The BIPP gauze is then introduced through the casing with crocodile forceps. The main advantage of this technique is improved visibility of the meatal skin flaps during placement of the gauze.

Bismuth iodoform paraffin paste and radiological imaging

Radiopaque marker strip

While BIPP itself is radiopaque, predominantly due to its bismuth content, BIPP gauze also contains a radiopaque marker strip. This consists of blue, multi-filament polypropylene yarn filled with barium sulphate and wrapped in a white polyester yarn that is dyed blue. The strip aids the radiographic detection of the gauze, should the BIPP paste become displaced (C Akinola, personal communication).

Computed tomography

The high attenuation of BIPP (>3000 Hounsfield units) results in severe image degradation and streak artefacts on computed tomography scanning. This is due mainly to BIPP's bismuth content. Betadine® gauze also has a high attenuation (258 Hounsfield units), but causes few streak artefacts. Calcium sodium alginate dressings have a similar attenuation to muscle.Reference Hartley, Ng and Jackson49

Magnetic resonance imaging

On magnetic resonance imaging, BIPP and calcium sodium alginate have imaging characteristics similar to muscle, whilst aqueous Betadine® gauze resembles bone marrow.Reference Hartley, Ng and Jackson49

Angiography

The radiopacity of BIPP is such that removal of nasal packing will usually be required prior to radiographically guided embolisation for persistent epistaxis.Reference Christensen, Smith, Barnwell and Wax50

Usage of BIPP in pregnancy and hyperthyroid patients

Iodine release from iodoform poses a theoretical risk when BIPP is used during pregnancy and in patients with metabolic thyroid disease.

If a patient has pre-existing hyperthyroidism, any iodine-containing compound may in theory exacerbate the condition, or even cause a thyrotoxic crisis.Reference Stanbury, Ermans, Bourdoux, Todd, Oken and Tonglet51 In practice, however, there have been no reports of this in relation to BIPP usage.

Iodine exists in equilibrium with its ionised form, iodide, which readily crosses the placenta.Reference Wolff52 Fetal hypothyroidism has been reported to occur as a result of repeated exposure to topical iodine.Reference Bachrach, Burrow and Gare53 However, short term exposure to iodine appears safe; iodine preparation given prior to maternal thyroid surgery rarely cause fetal problems.Reference Herbst and Selenkow54

Maternal exposure to excessive iodine may induce fetal hyperthyroidism or hypothyroidism.Reference Braverman and Ingbar55 In a number of reported cases, ‘congenital iodide goitre’ has resulted in tracheal compression and death.Reference Melvin, Aceto, Barlow, Munson and Wierda56, Reference Moosa and Williams57

However, there are no reported instances of fetal harm from BIPP usage.

Conclusion

This paper presents an overview of the constituents and side effects of BIPP-impregnated ribbon gauze, and alternatives to its use. Toxicity from BIPP usage is possible, even from the relatively modest quantities used in modern surgical practice. Allergy is not uncommon, and BIPP can also cause marked degradation of radiological imaging. Little information exists on its use in pregnancy and in thyroid disorders, where it poses a theoretical risk.

An increasing number of alternatives are becoming available for use in otological and rhinological practice.

References

1PubMed. In: http://www.ncbi.nlm.nih.gov/pubmed [13 February 2011]Google Scholar
2Morison, JR. BIPP Treatment of War Wounds. London, Henry Frowde: Hodder & Stoughton, 1918Google Scholar
3Fleming, A. The action of chemical and physiological antiseptics in a septic wound. Br J Surg 1919;7:99129CrossRefGoogle Scholar
4Gurd, FB, McKim, LH. B.I.P.P. and liquid paraffin treatment of war and civilian wounds. Ann Surg 1941;113:9871000CrossRefGoogle ScholarPubMed
5Garrett Anderson, L, Chambers, H. The treatment of septic wounds with bismuth iodofrom paraffin paste. Lancet 1917;i:331–3CrossRefGoogle Scholar
6Tilley, H. A series of consecutive cases in which the mastoid has been operated on for acute suppurative inflammation, B.I.P. (bismuth, iodoform, and liquid paraffin) inserted, and the external wound sutured in its entire length at the close of the operation. Proc R Soc Med 1918;11:6976Google ScholarPubMed
7Kampmeier, RH. Syphilis therapy: an historical perspective. J Am Vener Dis Assoc 1976;3:99108Google ScholarPubMed
8Chambers, S, Goldsmith, JN. The bacteriological and chemical action of bismuth iodoform paraffin paste. Lancet 1917;i:333–5CrossRefGoogle Scholar
9Nordberg, G. Handbook on the Toxicology of Metals, 3rd edn.Oxford: Academic, 2007;433–43Google Scholar
10Wilson, AP. The dangers of BIPP. Lancet 1994;344:1313–14CrossRefGoogle ScholarPubMed
11Robinson, HM. An evaluation of the bismuth blue line. J Invest Dermatol 1952;18:341–64CrossRefGoogle ScholarPubMed
12Le Quesne, PM. Metal-induced diseases of the nervous system. Br J Hosp Med 1982;28:534–8Google ScholarPubMed
13Youngman, L, Harris, S. BIPP madness; an iatrogenic cause of acute confusion. Age Ageing 2004;33:406–7CrossRefGoogle ScholarPubMed
14Bunn, HF, Forget, BG. Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia: WB Saunders, 1986;634–62Google Scholar
15Barker, SJ, Tremper, KK, Hyatt, J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 1989;70:112–17CrossRefGoogle ScholarPubMed
16Marcus, H, Joffe, JR. Nitrate methemoglobinemia. N Engl J Med 1949;240:599602CrossRefGoogle ScholarPubMed
17Nigam, A, Ruddy, J, Robin, PE. BIPP induced methaemoglobinaemia. J Laryngol Otol 1991;105:78–9CrossRefGoogle ScholarPubMed
18Nigam, A, Allwood, MC. BIPP – how does it work? Clin Otolaryngol Allied Sci 1990;15:173–5CrossRefGoogle ScholarPubMed
19O'Connor, AF, Freeland, AP, Heal, DJ, Rossouw, DS. Iodoform toxicity following the use of B.I.P.P.: a potential hazard. J Laryngol Otol 1977;91:903–7CrossRefGoogle ScholarPubMed
20Farrell, RW. Dangers of bismuth iodoform paraffin paste. Lancet 1994;344:1637–8CrossRefGoogle ScholarPubMed
21Lim, PV, Hughes, RG, Oates, J. Hypersensitive allergic reactions to bismuth-iodoform-paraffin paste following ear surgery. J Laryngol Otol 1998;112:335–7CrossRefGoogle ScholarPubMed
22Bennett, AM, Bartle, J, Yung, MW. Avoidance of BIPP allergy hypersensitivity reactions following ear surgery. Clin Otolaryngol 2008;33:32–4CrossRefGoogle ScholarPubMed
23Jones, PH. BIPP allergy causing facial paralysis. J Laryngol Otol 1985;99:389–90CrossRefGoogle ScholarPubMed
24Loescher, AR, Robinson, PP. The effect of surgical medicaments on peripheral nerve function. Br J Oral Maxillofac Surg 1998;36:327–32CrossRefGoogle ScholarPubMed
25Imison, A. BIPP aspiration. Anaesth Intensive Care 2000;28:335–6Google ScholarPubMed
26Flook, E, Elloy, M, Johnston, M. Meatoplasty technique which avoids using a roll of BIPP. Clin Otolaryngol 2008;33:179–80CrossRefGoogle ScholarPubMed
27Chevretton, EB, McRae, RD, Booth, JB. Mastoidectomy packs: Xeroform or BIPP? J Laryngol Otol 1991;105:916–17CrossRefGoogle ScholarPubMed
28Corbridge, RJ, Djazaeri, B, Hellier, WP, Hadley, J. A prospective randomized controlled trial comparing the use of merocel nasal tampons and BIPP in the control of acute epistaxis. Clin Otolaryngol Allied Sci 1995;20:305–7CrossRefGoogle ScholarPubMed
29Saab, M, Randall, PE. Nasal packing for epistaxis: two methods compared. Eur J Emerg Med 1997;4:44Google ScholarPubMed
30McDonald, SE, Slater, J, Powell, R, Khalil, HS, Garth, RJ. A randomised controlled trial comparing Rapid Rhino Mannheim and Netcell series 5000 packs following routine nasal surgery. Rhinology 2009;47:41–4Google ScholarPubMed
31Badran, K, Malik, TH, Belloso, A, Timms, MS. Randomized controlled trial comparing Merocel and RapidRhino packing in the management of anterior epistaxis. Clin Otolaryngol 2005;30:333–7CrossRefGoogle ScholarPubMed
32Moumoulidis, I, Draper, MR, Patel, H, Jani, P, Price, T. A prospective randomised controlled trial comparing Merocel and Rapid Rhino nasal tampons in the treatment of epistaxis. Eur Arch Otorhinolaryngol 2006;263:719–22CrossRefGoogle ScholarPubMed
33Bajaj, Y, Kanatas, AN, Carr, S, Sethi, N, Kelly, G. Is nasal packing really required after septoplasty? Int J Clin Pract 2009;63:757–9CrossRefGoogle ScholarPubMed
34Ozcan, C, Vayisoglu, Y, Kilic, S, Gorur, K. Comparison of Rapid Rhino and Merocel nasal packs in endonasal septal surgery. J Otolaryngol Head Neck Surg 2008;37:826–31Google ScholarPubMed
35Lim, M, Lew-Gor, S, Sandhu, G, Howard, D, Lund, VJ. Whitehead's varnish nasal pack. J Laryngol Otol 2007;121:592–4CrossRefGoogle ScholarPubMed
36McGlashan, JA, Walsh, R, Dauod, A, Vowles, A, Gleeson, MJ. A comparative study of calcium sodium alginate (Kaltostat) and bismuth tribromophenate (Xeroform) packing in the management of epistaxis. J Laryngol Otol 1992;106:1067–71CrossRefGoogle ScholarPubMed
37Kamer, FM, Parkes, ML. An absorbent, non-adherent nasal pack. Laryngoscope 1975;85:384–8CrossRefGoogle ScholarPubMed
38Chandra, RK, Conley, DB, Kern, RC. The effect of FloSeal on mucosal healing after endoscopic sinus surgery: a comparison with thrombin-soaked gelatin foam. Am J Rhinol 2003;17:51–5CrossRefGoogle ScholarPubMed
39Cote, D, Barber, B, Diamond, C, Wright, E. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial. J Otolaryngol Head Neck Surg 2010;39:304–8Google ScholarPubMed
40Mathiasen, RA, Cruz, RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 2005;115:899902CrossRefGoogle ScholarPubMed
41Cote, DW, Wright, ED. Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study. Laryngoscope 2010;120:1269–73CrossRefGoogle ScholarPubMed
42Shoman, N, Gheriani, H, Flamer, D, Javer, A. Prospective, double-blind, randomized trial evaluating patient satisfaction, bleeding, and wound healing using biodegradable synthetic polyurethane foam (NasoPore) as a middle meatal spacer in functional endoscopic sinus surgery. J Otolaryngol Head Neck Surg 2009;38:112–18Google ScholarPubMed
43Bhatnagar, RK, Berry, S. Selective Surgicel packing for the treatment of posterior epistaxis. Ear Nose Throat J 2004;83:633–4CrossRefGoogle ScholarPubMed
44Amen, F, Pace-Balzan, A. Technical tutorial: how to pack a nose with bismuth iodoform paraffin paste gauze safely and effectively. Emerg Med J 2009;26:52CrossRefGoogle Scholar
45Pettineo, CM, Vozenilek, JA, Kharasch, M, Wang, E, Aitchison, P. Epistaxis simulator: an innovative design. Simul Healthc 2008;3:239–41CrossRefGoogle ScholarPubMed
46Thomas, S, Pringle, M. The use of airway mannequins to improve the teaching of nasal packing. Clin Otolaryngol 2006;31:563–4CrossRefGoogle ScholarPubMed
47Skilbeck, CJ, Oakley, R. The fist model for nasal packing. Eur J Emerg Med 2006;13:97–8CrossRefGoogle ScholarPubMed
48Bernstein, JM, Aucott, W. The BIPP introducer. Clin Otolaryngol 2009;34:402–3CrossRefGoogle ScholarPubMed
49Hartley, C, Ng, KL, Jackson, A. CT and MR appearance of otolaryngologic packing materials. AJNR Am J Neuroradiol 1995;16:1697–702Google Scholar
50Christensen, NP, Smith, DS, Barnwell, SL, Wax, MK. Arterial embolization in the management of posterior epistaxis. Otolaryngol Head Neck Surg 2005;133:748–53CrossRefGoogle ScholarPubMed
51Stanbury, JB, Ermans, AE, Bourdoux, P, Todd, C, Oken, E, Tonglet, R et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998;8:83100CrossRefGoogle ScholarPubMed
52Wolff, J. Iodide goiter and the pharmacologic effects of excess iodide. Am J Med 1969;47:101–24CrossRefGoogle ScholarPubMed
53Bachrach, LK, Burrow, GN, Gare, DJ. Maternal-fetal absorption of povidone-iodine. J Pediatr 1984;104:158–9CrossRefGoogle ScholarPubMed
54Herbst, AL, Selenkow, HA. Hyperthyroidism during pregnancy. N Engl J Med 1965;273:627–33CrossRefGoogle ScholarPubMed
55Braverman, LE, Ingbar, SH. Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 1963;42:1216–31CrossRefGoogle ScholarPubMed
56Melvin, GR, Aceto, T Jr, Barlow, J, Munson, D, Wierda, D. Iatrogenic congenital goiter and hypothyroidism with respiratory distress in a newborn. S D J Med 1978;31:1519Google ScholarPubMed
57Moosa, A, Williams, F. Congenital iodide goitre – a continuing iatrogenic problem. S Afr Med J 1977;51:490Google ScholarPubMed